LI2P - 2008

Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA. Kloss M*, Decker P*, Baltz K, Baessler T, Jung G, Rammensee HG, Steinle A, Krusch M, Salih H. J Immunol, 2008, 181: 6711-19. *The first two authors contributed equally to this work.
The PDE4 inhibitor rolipram prevents NF-kappaB binding activity and proinflammatory cytokine release in human chorionic cells. Hervé R, Schmitz T, Evain-Brion D, Cabrol D, Leroy MJ, Méhats C. J Immunol. 2008 Aug 1;181(3):2196-202.
Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo. Jaen O, Rullé S, Bessis N, Zago A, Boissier MC, Falgarone G. . Immunology. 2009;126:35-44..
Budget impact model of rituximab after failure of one or more TNFalpha inhibitor therapies in the treatment of rheumatoid arthritis. Launois R, Payet S, Saidenberg-Kermanac'h N, Francesconi C, França LR, Boissier MC. Joint Bone Spine. 2008;75:688-95.
Shifting the imbalance from Th1/Th2 to Th17/treg: the changing rheumatoid arthritis paradigm. Boissier MC, Assier E, Falgarone G, Bessis N. Joint Bone Spine. 2008;75:373-5.
ltrasound and Doppler micro-imaging in a model of rheumatoid arthritis in mice. Clavel G, Marchiol-Fournigault C, Renault G, Boissier MC, Fradelizi D, Bessis N. U Ann Rheum Dis. 2008 ;67:1765-72.
Emerging applications of anticytokine vaccines. Delavallée L, Assier E, Semerano L, Bessis N, Boissier MC. . Expert Rev Vaccines. 2008;7:1507-17.
Vaccination with cytokines in autoimmune diseases. Delavallée L, Assier E, Denys A, Falgarone G, Zagury JF, Muller S, Bessis N, Boissier MC Ann Med. 2008;40:343-51.
Arly and long-lasting protection from arthritis in tumour necrosis factor alpha (TNFalpha) transgenic mice vaccinated against TNFalpha. Delavallée L, Le Buanec H, Bessis N, Assier E, Denys A, Bizzini B, Zagury D, Boissier MC. E Ann Rheum Dis. 2008;67:1332-8.

2008

Publications du Li2P INSERM UMR 1125

2008

USPN Campus de Bobigny